NYSSA Presents 10th Annual Biotech/Specialty Pharma Conference.NEW YORK -- The New York Society of Security Analysts (NYSSA Nyssa (nĭs`ə), name of several ancient cities devoted to the worship of Dionysus. The best known of them is a town of Cappadocia, Asia Minor, near the Halys (now the Kizil Irmak) River. It was the residence of St. Gregory of Nyssa. ) will present the 10th Annual Biotech/Specialty Pharma Conference on December 12 to 13, 2006. What does the future have in store for the biotech industry? Don't miss this chance to hear Michael D. West Dr. Michael D. West is an entrepreneurial scientist and visionary [1] [2] [3] [4] who has led progress in anti-aging and biotechnology. He is CEO of BioTime, Inc. , PhD, president of Advanced Cell Technology and author of The Immortal Cell: One Scientist's Quest to Solve the Mystery of Human Aging, discuss the emerging field of stem cell research. Other presentations include companies focused on hormone therapy, drug delivery and treatments for HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and cancer. The following companies are presenting on day one: Aradigm Corporation (Nasdaq: ARDM); BioSante Pharmaceuticals, Inc. (AMEX AMEX See: American Stock Exchange : BPA BPA British Paediatric Association. ); CytRx Corporation (Nasdaq: CYTR); DNAPrint Genomics, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : DNAG); DRAXIS Health Inc. (Nasdaq: DRAX; TSX: DAX); DURECT Corporation (Nasdaq: DRRX); Heska Corporation (Nasdaq: HSKA); The Immune Response Corporation (OTCBB: IMNR); Viral Genetics, Inc. (OTCBB: VRAL); and Xechem International, Inc. (OTCBB: XKEM). The following companies are presenting on day two: Advanced Cell Technology, Inc. (OTCBB: ACTC); Cleveland BioLabs, Inc. (Nasdaq: CBLI); Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC); EntreMed, Inc. (Nasdaq: ENMD); Neuro-Hitech Pharmaceuticals, Inc. (OTCBB: NHPI); Provectus Pharmaceuticals, Inc. (OTCBB: PVCT PVCT posterior vena caval thrombosis. ); The Quigley Corporation (Nasdaq: QGLY); and XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB). The conference will be held on December 12, 2006, 8:30 a.m. to 5:10 p.m., and December 13, 2006, 8:30 a.m. to 4:30 p.m. at NYSSA, 1177 Avenue of the Americas, 2nd Floor, NYC. Registration deadline is December 5, one day, $265 NYSSA members, $365 nonmembers; two days, $365 NYSSA members, $465 nonmembers. No charge for press with credentials. A complete agenda is available at http://www.nyssa.org/Template.cfm?Section=conferences___ seminars&template=/ContentManagement/ContentDisplay.cfm&ContentID=8977 (Due to its length, this URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) About NYSSA NYSSA, established in 1937, is the premier independent forum for the exchange of information among investment decision-makers. A not-for-profit educational organization with over 9,500 members, NYSSA is committed to the promotion of best practices and the highest professional and ethical standards in the investment industry. NYSSA is the largest of the more than 134 societies worldwide that make up CFA Institute, which has more than 83,000 members. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion